Pharmaceutical composition for inhibition of cancer cell metastasis including siRNA for ribosomal protein S3
AssigneeJoon Kim
InventorsJoon Kim, Hag Dong Kim, YongJoong Kim
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for inhibiting cancer cell metastasis, the pharmaceutical composition including at least one of: (1) si-rpS3/203 binding to a 203rd base sequence of rpS3 mRNA; (2) si-rpS3/635 binding to a base sequence corresponding to a position 635 of the rpS3 mRNA; (3) si-rpS3/747 binding to a base sequence corresponding to a position 747 of the rpS3 mRNA; and (4) si-rpS3/766 binding to a base sequence corresponding to a position 766 of the rpS3 mRNA.
Claims2
A pharmaceutical composition for inhibiting cancer cell metastasis, the pharmaceutical composition comprising at least one of:
- si-rpS3/203 binding to a 203rd base sequence of rpS3 mRNA, wherein the si-rpS3/203 is represented by a base sequence of SEQ ID NO:
- 1.
A pharmaceutical composition for inhibiting cancer cell metastasis, the pharmaceutical composition comprising si-rpS3/635 binding to a 635th base sequence of rpS3 mRNA,
- wherein the si-rpS3/635 is represented by a base sequence of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.